Cytotoxic activity and HDAC inhibition [IC50 (μM)] of compounds 1-20 and vorinostat against human colon cancer (HCT116), human cervical (HeLa), lung (A549) and ovarian cancer (A2780) cell lines. This evidence concerns the gene HDAC9 and ovarian carcinoma.